Cognitive dysfunction and depression in older adults with diabetes

Geriatric Diabetes

Volumn , Issue , 2007, Pages 63-84

  Kuo, Hsu Ko ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 63349107249     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (123)

1. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001; 24(11): 1936-1940.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21(9): 1414-1431.
3. Leifer BP. Early diagnosis of Alzheimer’s disease: clinical and economic benefits. J Am Geriatr Soc 2003; 51(5 suppl Dementia): S281-S288.
4. Roman GC. Vascular dementia: distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc 2003; 51(5 suppl Dementia): S296-S304.
5. Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999; 16(2): 93-112.
6. Vanhanen M, Soininen H. Glucose intolerance, cognitive impairment and Alzheimer’s disease. Curr Opin Neurol 1998; 11(6): 673-677.
7. Elias PK, Elias MF, D’Agostino RB, et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham study. Diabetes Care 1997; 20(9): 1388-1395.
8. Grodstein F, Chen J, Wilson RS, Manson JE. Type 2 diabetes and cognitive function in communitydwelling elderly women. Diabetes Care 2001; 24(6): 1060-1065.
9. Arvanitakis Z, Wilson RS, Li Y, Aggarwal NT, Bennett DA. Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 2006; 29(3): 560-565.
10. Gregg EW, Yaffe K, Cauley JA, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of osteoporotic fractures research group. Arch Intern Med 2000; 160(2): 174-180.
11. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middleaged adults. Neurology 2001; 56(1): 42-48.
12. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the epidemiology of vascular aging study. Diabetes Care 2001; 24(2): 366-370.
13. Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH. Impact of diabetes on cognitive function among older Latinos: a population-based cohort study. J Clin Epidemiol 2003; 56(7): 686-693.
14. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004; 63(4): 658-663.
15. Hassing LB, Grant MD, Hofer SM, et al. Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. J Int Neuropsychol Soc 2004; 10(4): 599-607.
16. Hassing LB, Hofer SM, Nilsson SE, et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 2004; 33(4): 355-361.
17. Logroscino G, Kang JH, Grodstein F. Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ 2004; 328(7439): 548.
18. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004; 61(5): 661-666.
19. Kuo HK, Jones RN, Milberg WP, et al. Effect of blood pressure and diabetes mellitus on cognitive and physical functions in older adults: a longitudinal analysis of the advanced cognitive training for independent and vital elderly cohort. J Am Geriatr Soc 2005; 53(7): 1154-1161.
20. Kokmen E, Whisnant JP, O’Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population- based study in Rochester, Minnesota (1960-1984). Neurology 1996; 46(1): 154-159.
21. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347(9009): 1141-1145.
22. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996; 39(11): 1392-1397.
23. Hassing LB, Johansson B, Nilsson SE, et al. Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer’s disease: a population-based study of the oldest old. Int Psychogeriatr 2002; 14(3): 239-248.
24. Leibson CL, Rocca WA, Hanson VA, et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 1997; 145(4): 301-308.
25. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001; 154(7): 635-641.
26. MacKnight C, Rockwood K, Awalt E, McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer’s disease and vascular cognitive impairment in the Canadian study of health and aging. Dement Geriatr Cogn Disord 2002; 14(2): 77-83.
27. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 1999; 53(9): 1937-1942.
28. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes 2002; 51(4): 1256-1262.
29. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 2004; 63(7): 1181-1186.
30. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: the Hisayama study. Neurology 1995; 45(6): 1161-1168.
31. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5(1): 64-74.
32. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005; 48(12): 2460-2469.
33. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101(4): 527-537.
34. Monnier VM, Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 1981; 211(4481): 491-493.
35. Smith MA, Taneda S, Richey PL, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A 1994; 91(12): 5710-5714.
36. Vitek MP, Bhattacharya K, Glendening JM, et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A 1994; 91(11): 4766-4770.
37. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414(6865): 813-820.
38. Du XL, Edelstein D, Rossetti L, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 2000; 97(22): 12222-12226.
39. McAulay V, Deary IJ, Ferguson SC, Frier BM. Acute hypoglycemia in humans causes attentional dysfunction while nonverbal intelligence is preserved. Diabetes Care 2001; 24(10): 1745-1750.
40. McAulay V, Deary IJ, Sommerfield AJ, Frier BM. Attentional functioning is impaired during acute hypoglycaemia in people with Type 1 diabetes. Diabet Med 2006; 23(1): 26-31.
41. Warren RE, Allen KV, Sommerfield AJ, Deary IJ, Frier BM. Acute hypoglycemia impairs nonverbal intelligence: importance of avoiding ceiling effects in cognitive function testing. Diabetes Care 2004; 27(6): 1447-1448.
42. Ewing FM, Deary IJ, McCrimmon RJ, Strachan MW, Frier BM. Effect of acute hypoglycemia on visual information processing in adults with type 1 diabetes mellitus. Physiol Behav 1998; 64(5): 653-660.
43. Strachan MW, Ewing FM, Frier BM, McCrimmon RJ, Deary IJ. Effects of acute hypoglycaemia on auditory information processing in adults with Type I diabetes. Diabetologia 2003; 46(1): 97-105.
44. Zhao WQ, Alkon DL. Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 2001; 177(1-2): 125-134.
45. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002; 297(5580): 353-356.
46. Gasparini L, Gouras GK, Wang R, et al. Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 2001; 21(8): 2561-2570.
47. Farris W, Mansourian S, Chang Y, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 2003; 100(7): 4162-4167.
48. Watson GS, Peskind ER, Asthana S, et al. Insulin increases CSF Aβ42 levels in normal older adults. Neurology 2003; 60(12): 1899-1903.
49. Okereke O, Hankinson SE, Hu FB, Grodstein F. Plasma C peptide level and cognitive function among older women without diabetes mellitus. Arch Intern Med 2005; 165(14): 1651-1656.
50. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004; 63(7): 1187-1192.
51. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005; 64(2): 277-281.
52. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005; 62(10): 1556-1560.
53. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebocontrolled systolic hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352(9137): 1347-1351.
54. Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163(9): 1069-1075.
55. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002; 59(3): 378-384.
56. Hajjar I, Schumpert J, Hirth V, Wieland D, Eleazer GP. The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J Gerontol A Biol Sci Med Sci 2002; 57(7): M414-M418.
57. Gradman TJ, Laws A, Thompson LW, Reaven GM. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993; 41(12): 1305-1312.
58. Meneilly GS, Cheung E, Tessier D, Yakura C, Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 1993; 48(4): M117-M121.
59. Wu JH, Haan MN, Liang J, Ghosh D, Gonzalez HM, Herman WH. Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 2003; 13(5): 369-376.
60. Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F. Physical activity, including walking, and cognitive function in older women. JAMA 2004; 292(12): 1454-1461.
61. Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H. Walking and dementia in physically capable elderly men. JAMA 2004; 292(12): 1447-1453.
62. Munshi M, Grande L, Hayes M, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006; 29(8): 1794-1799.
63. Perlmuter LC, Hakami MK, Hodgson-Harrington C, et al. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 1984; 77(6): 1043-1048.
64. Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract 2000; 50(3): 203-212.
65. Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51(5 suppl Guidelines): S265-S280.
66. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24(6): 1069-1078.
67. Lustman PJ, Griffith LS, Freedland KE, Clouse RE. The course of major depression in diabetes. Gen Hosp Psychiatry 1997; 19(2): 138-143.
68. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25(3): 464-470.
69. Bell RA, Smith SL, Arcury TA, Snively BM, Stafford JM, Quandt SA. Prevalence and correlates of depressive symptoms among rural older African Americans, Native Americans, and whites with diabetes. Diabetes Care 2005; 28(4): 823-829.
70. Bruce DG, Casey GP, Grange V, et al. Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle cognition in diabetes study. Diabetes Res Clin Pract 2003; 61(1): 59-67.
71. Chou KL, Chi I. Prevalence of depression among elderly Chinese with diabetes. Int J Geriatr Psychiatry 2005; 20(6): 570-575.
72. Finkelstein EA, Bray JW, Chen H, et al. Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 2003; 26(2): 415-420.
73. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. “Vascular depression” hypothesis. Arch Gen Psychiatry 1997; 54(10): 915-922.
74. Kessing LV, Nilsson FM, Siersma V, Andersen PK. No increased risk of developing depression in diabetes compared to other chronic illness. Diabetes Res Clin Pract 2003; 62(2): 113-121.
75. Palinkas LA, Lee PP, Barrett-Connor E. A prospective study of Type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo study. Diabet Med 2004; 21(11): 1185-1191.
76. Bisschop MI, Kriegsman DM, Deeg DJ, Beekman AT, van Tilburg W. The longitudinal relation between chronic diseases and depression in older persons in the community: the longitudinal aging study Amsterdam. J Clin Epidemiol 2004; 57(2): 187-194.
77. Geringer E. Affective disorders and dibetes mellitus. In: Neuropsychological and Behavioral Aspect of Diabetes. New York: Springer-Verlag, 1990.
78. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19(10): 1097-1102.
79. Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999; 22(7): 1071-1076.
80. Everson-Rose SA, Meyer PM, Powell LH, et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004; 27(12): 2856-2862.
81. Arroyo C, Hu FB, Ryan LM, et al. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004; 27(1): 129-133.
82. Golden SH, Williams JE, Ford DE, et al. Depressive symptoms and the risk of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care 2004; 27(2): 429-435.
83. Hayward C. Psychiatric illness and cardiovascular disease risk. Epidemiol Rev 1995; 17(1): 129-138.
84. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 2000; 23(10): 1556-1562.
85. Brown LC, Majumdar SR, Newman SC, Johnson JA. History of depression increases risk of type 2 diabetes in younger adults. Diabetes Care 2005; 28(5): 1063-1067.
86. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000; 23(7): 934-942.
87. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63(4): 619-630.
88. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 2002; 72(3): 227-236.
89. Sheps DS, McMahon RP, Becker L, et al. Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: results from the psychophysiological investigations of myocardial ischemia study. Circulation 2002; 105(15): 1780-1784.
90. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105(9): 1049-1053.
91. Lewis SC, Dennis MS, O’Rourke SJ, Sharpe M. Negative attitudes among short-term stroke survivors predict worse long-term survival. Stroke 2001; 32(7): 1640-1645.
92. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161(15): 1849-1856.
93. Berkman LF, Melchior M, Chastang JF, Niedhammer I, Leclerc A, Goldberg M. Social integration and mortality: a prospective study of French employees of electricity of France-Gas of France: the GAZEL cohort. Am J Epidemiol 2004; 159(2): 167-174.
94. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 2005; 161(7): 652-660.
95. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005; 28(6): 1339-1345.
96. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28(11): 2668-2672.
97. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160(21): 3278-3285.
98. Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004; 27(9): 2154-2160.
99. Kilbourne AM, Reynolds CF III, Good CB, Sereika SM, Justice AC, Fine MJ. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry 2005; 13(3): 202-210.
100. Wray LA, Ofstedal MB, Langa KM, Blaum CS. The effect of diabetes on disability in middle-aged and older adults. J Gerontol A Biol Sci Med Sci 2005; 60(9): 1206-1211.
101. Lyness JM, King DA, Cox C, Yoediono Z, Caine ED. The importance of subsyndromal depression in older primary care patients: prevalence and associated functional disability. J Am Geriatr Soc 1999; 47(6): 647-652.
102. Egede LE. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 2004; 27(2): 421-428.
103. Egede LE. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care 2004; 27(7): 1751-1753.
104. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004; 27(5): 1066-1070.
105. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003; 26(10): 2822-2828.
106. Rubin RR, Ciechanowski P, Egede LE, Lin EH, Lustman PJ. Recognizing and treating depression in patients with diabetes. Curr Diab Rep 2004; 4(2): 119-125.
107. Lustman PJ, Harper GW. Nonpsychiatric physicians’ identification and treatment of depression in patients with diabetes. Compr Psychiatry 1987; 28(1): 22-27.
108. Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck depression inventory. Psychosom Med 1997; 59(1): 24-31.
109. Wright MJ, White A, Glover M, Lewin TJ, Harmon KD. Patients with diabetes and impaired glucose tolerance-is it feasible to screen for depression? Aust Fam Physician 2005; 34(7): 607-608.
110. Rakovac I, Gfrerer RJ, Habacher W, et al. Screening of depression in patients with diabetes mellitus. Diabetologia 2004; 47(8): 1469-1470.
111. Goodnick PJ, Kumar A, Henry JH, Buki VM, Goldberg RB. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull 1997; 33(2): 261-264.
112. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000; 23(5): 618-623.
113. Furman BL. The hypoglycaemic effect of 5-hydroxytryptophan. Br J Pharmacol 1974; 50(4): 575-580.
114. Wilson GA, Furman BL. Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycaemia in mice. Eur J Pharmacol 1982; 78(3): 263-270.
115. Potter van Loon BJ, Radder JK, Frolich M, Krans HM, Zwinderman AH, Meinders AE. Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes Relat Metab Disord 1992; 16(2): 79-85.
116. Ferguson JM, Feighner JP. Fluoxetine-induced weight loss in overweight non-depressed humans. Int J Obes 1987; 11(suppl 3): 163-170.
117. Harris B, Young J, Hughes B. Changes occurring in appetite and weight during short-term antidepressant treatment. Br J Psychiatry 1984; 145: 645-648.
118. Paykel ES, Mueller PS, De la Vergne PM. Amitriptyline, weight gain and carbohydrate craving: a side effect. Br J Psychiatry 1973; 123(576): 501-507.
119. Practice Guideline for Major Depressive Disorder in Adults. Washington, DC: American Psychiatric Association, 1993.
120. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998; 129(8): 613-621.
121. Walsh EG, Osber DS, Nason CA, Porell MA, Asciutto AJ. Quality improvement in a primary care case management program. Health Care Financ Rev 2002; 23(4): 71-84.
122. Williams JW Jr, Katon W, Lin EH, et al. The effectiveness of depression care management on diabetes- related outcomes in older patients. Ann Intern Med 2004; 140(12): 1015-1024.
123. Katon WJ, Von Korff M, Lin EH, et al. The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004; 61(10): 1042-1049.